Retroviral human CPT1A WT and G710E constructs were kindly provided by Taro Hitosugi from Mayo Clinic. These plasmids were pLHCX-hygro- Gateway destination vector-based and were constructed as previously described144. Each of the pLHCX vector plasmid (RV), CPT1A WT (RW), and CPT1A G710E (RM) plasmid was co-transfected with packaging plasmids (EcoPac, pAmphopac, pVSVG) into HEK293T (Sigma-Aldrich) cells using lipofectamine 2000. Retrovirus was harvested 48 h after transfection, filtered w/ 0.45 μm filter, and 8 μg/ml final concentration of polybrene was added. Retroviral infection of the PEO1 WT (A3) and PEO1-CPT1A KO clones (B85), PEO4 WT (C5) and PEO4-CPT1A KO clones (C6) was conducted with freshly harvested retrovirus. Infected cell lines were selected in 25 μg/ml hygromycin for 3 weeks to obtain stable cell lines. Stable expression of the CPT1A WT and G710E mutant protein was verified by western blot of cell lysates as described below.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.